Yoshishima

Materialise NV (MTLS)

Description

Materialise NV is a Belgian‐based leader in additive manufacturing, providing a comprehensive portfolio of software platforms and complex 3D printing services across medical, industrial and consumer markets.

Historical Reports

Financial Information

Report Date
2025-04-30
Report Period
Fiscal Year 2024
Debt
€413 million
Debt History
Shrinking by 36% year-over-year
Debt Trend
Decreasing

Profit Information

Profit
€13.4 million
Profit History
Increasing by 100% year-over-year
Profit Trend
Increasing

Detailed Report

Materialise NV Financial Report

Report Date: 2025-04-30
Period Covered: Fiscal Year Ended December 31, 2024

1. Overview and Highlights

  • Total revenue grew to €266.8 million, up 4.2% from €256.1 million in 2023.
  • Net profit rose to €13.4 million (5.0% margin), compared with €6.7 million in 2023.
  • EBITDA climbed to €31.2 million, up from €27.1 million a year earlier.
  • Net debt fell to €41.3 million, down 36% from €64.4 million, driven by strong cash flow and disciplined capex.

2. Profit & Debt Analysis

  • Revenue drivers: Medical segment (+14.8%), Software (–1.1%), Manufacturing (–3.5%).
  • Profit jump: Higher gross margins (56.5% vs. 56.7%) and operating leverage lifted net income by 100%.
  • Debt reduction: Ending net debt/EBITDA improved significantly, strengthening the balance sheet.

3. Reasons for Performance

Positive factors

  • Rapid growth in personalized medical planning and devices
  • Continued migration to cloud-based software licenses with recurring revenue
  • Tight cost control and improved operating efficiency

Headwinds

  • Slower industrial production amid macro uncertainty
  • Inflationary cost pressure on materials and energy
  • Ongoing R&D investment dampening near-term operating profit

4. Pros and Cons

Pros

  • Diversified, synergistic software-and-services model
  • Leading edge in medical additive manufacturing
  • Strong cash generation and improving leverage metrics

Cons

  • Exposure to cyclical industrial end markets
  • High R&D spend in a competitive environment
  • Currency and geopolitical risks in global operations

Statistics Breakdown

2024 Revenue Split by Segment:

  • Medical: €116.4 M (43.6%)
  • Software: €43.9 M (16.5%)
  • Manufacturing: €106.5 M (39.9%)

2024 Revenue by Region:

  • Americas: €108.6 M (40.7%)
  • Europe & Africa: €133.6 M (50.1%)
  • Asia-Pacific: €18.1 M (6.8%)

2024 EBITDA by Segment:

  • Medical: €35.6 M (30.6% margin)
  • Software: €5.6 M (12.7% margin)
  • Manufacturing: €16.6 M (15.6% margin)

Company Direction Insights

Materialise NV is transitioning its software business to a subscription-based, cloud-native model (CO-AM platform) while scaling its medical and industrial printing services.

Growth trajectory: Software recurring revenue and personalized medical planning tools are poised for double-digit growth.

Financial health: Rapid debt paydown and expanding EBITDA margins provide a solid base for strategic M&A and continued R&D.

Future challenges: Navigating inflation, industrial demand swings, and intensifying competition in additive manufacturing software and services.